CLINICAL_TRIALS
trial_result
· 2020-09-25
Clinical Trial Update: Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria. [Phase 2]
Summary
Phase 2 trial assessing safety of KAE609 in adults with uncomplicated Plasmodium falciparum malaria has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2020-09-25